News

Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase Development Award to $US 5M

14 March 2018

Laurent Pharmaceuticals Inc. (the “Company”), today announced that it has reached an agreement to receive an additional US$ 2 million commitment...

Read More

Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis

19 April 2017

Laurent Pharmaceuticals Inc., a clinical stage orphan drug company, today announced the clearance of its Investigational New DrugApplication (“IND”) with the...

Read More

EVENTS

Laurent Pharma to participate to H.C. Wainwright 23rd Annual Global Investment Conference, September 13-15, 2021